Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.2 USD -4.16% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Supernus Pharmaceuticals Inc
Operating Expenses Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Operating Expenses
-$521.3m
CAGR 3-Years
-13%
CAGR 5-Years
-16%
CAGR 10-Years
-19%
Johnson & Johnson
NYSE:JNJ
Operating Expenses
-$36.5B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Expenses
-$24.9B
CAGR 3-Years
2%
CAGR 5-Years
-24%
CAGR 10-Years
-11%
Pfizer Inc
NYSE:PFE
Operating Expenses
-$29.4B
CAGR 3-Years
-11%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Merck & Co Inc
NYSE:MRK
Operating Expenses
-$26.7B
CAGR 3-Years
-11%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Eli Lilly and Co
NYSE:LLY
Operating Expenses
-$18.6B
CAGR 3-Years
-12%
CAGR 5-Years
-10%
CAGR 10-Years
-5%

See Also

What is Supernus Pharmaceuticals Inc's Operating Expenses?
Operating Expenses
-521.3m USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's Operating Expenses amounts to -521.3m USD.

What is Supernus Pharmaceuticals Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-19%

Over the last year, the Operating Expenses growth was -6%. The average annual Operating Expenses growth rates for Supernus Pharmaceuticals Inc have been -13% over the past three years , -16% over the past five years , and -19% over the past ten years .

Back to Top